Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TSPO ligands in the treatment of depression
DRKS00031099Phase 2Completed
- Sponsor
- medbo
- Start
- Jan 2023
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive episode (MDE), recurrent depressive disorder (RDD) and bipolar disorder (BD) comparing Etifoxine with Placebo (2 arms). Started Jan 2023; status: completed.
02
Drugs
etifoxine
03
Conditions
major depressive episode (MDE)recurrent depressive disorder (RDD)bipolar disorder (BD)
Beyond the preview
Go deeper on DRKS00031099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00031099.